rs140948493
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001369.3(DNAH5):c.11437C>T(p.Arg3813Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00144 in 1,613,698 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001369.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.11437C>T | p.Arg3813Trp | missense_variant | Exon 66 of 79 | 1 | NM_001369.3 | ENSP00000265104.4 | ||
DNAH5 | ENST00000681290.1 | c.11392C>T | p.Arg3798Trp | missense_variant | Exon 66 of 79 | ENSP00000505288.1 |
Frequencies
GnomAD3 genomes AF: 0.00107 AC: 163AN: 151792Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00122 AC: 306AN: 251212Hom.: 1 AF XY: 0.00123 AC XY: 167AN XY: 135776
GnomAD4 exome AF: 0.00147 AC: 2156AN: 1461788Hom.: 3 Cov.: 31 AF XY: 0.00144 AC XY: 1047AN XY: 727198
GnomAD4 genome AF: 0.00107 AC: 163AN: 151910Hom.: 0 Cov.: 33 AF XY: 0.000970 AC XY: 72AN XY: 74248
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19357118, 34426522, 24498942) -
BS1, PP3 -
Primary ciliary dyskinesia 3 Uncertain:2
- -
- -
Primary ciliary dyskinesia Uncertain:1Benign:1
- -
The p.R3813W variant (also known as c.11437C>T), located in coding exon 66 of the DNAH5 gene, results from a C to T substitution at nucleotide position 11437. The arginine at codon 3813 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was identified in an adult with a history of neonatal respiratory distress, otitis media, bronchiectasis, sinusitis and outer dynein arm defects on electron microscopy. This individual was also heterozygous for a nonsense alteration in DNAH5; however, the phase of these alterations was not provided (Kim RH et al. Ann Am Thorac Soc, 2014 Mar;11:351-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Uncertain:1
The p.Arg3813Trp variant in DNAH5 has been previously reported in 1 compound het erozygous child with primary ciliary dyskinesia (PCD) (Kim 2014). This variant h as also been identified in 0.24% (159/66720) of Non-Finnish European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSN P rs397515393). Computational prediction tools and conservation analysis sugges t that this variant may impact the protein, though this information is not predi ctive enough to determine pathogenicity. In summary, the clinical significance o f the p.Arg3813Trp variant is uncertain. -
DNAH5-related disorder Uncertain:1
The DNAH5 c.11437C>T variant is predicted to result in the amino acid substitution p.Arg3813Trp. This variant was reported in the compound heterozygous state in an individual with primary ciliary dyskinesia (Table 1, Kim et al. 2014. PubMed ID: 24498942). This variant is reported in 0.34% of alleles in individuals of Ashkenazi Jewish descent in gnomAD, including one homozygous observation. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at